Krsnaa Diagnostics has acquired strategic stake in Apulki Healthcare, India’s first Public Private Partnership (PPP) dedicated for cancer and cardiac care hospital. Under this collaboration, Krsnaa will deliver a comprehensive suite of integrated diagnostic services at Apulki’s facilities, enhancing access to advanced and super specialized diagnostics.
Under this collaboration, Krsnaa Diagnostics will become the exclusive diagnostics partner for Apulki’s state-of-the-art cancer and cardiac hospitals for the next 30 plus years. This ensures Krsnaa's sustained leadership in the high-growth oncology and cardiac diagnostic segments, with access to Apulki’s planned network of 10 plus hospitals across India. The initial rollout includes two advanced 125 plus bedded hospitals in densely populated regions of Pune and Mumbai, with more hospitals to follow in other metropolitan areas. This initiative will cater to the unmet demand for specialized diagnostics, helping improve outcomes for patients from all socioeconomic backgrounds.
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.
Company Name | CMP |
---|---|
Apollo Hospital Ent. | 7006.00 |
Max Healthcare Inst | 1115.25 |
Narayana Hrudayalay | 1799.25 |
Aster DM Healthcare | 513.80 |
Global Health | 1190.45 |
View more.. |